πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Mineralys Therapeutics, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Aytu BioPharma, Inc.

Aytu BioPharma, Inc. logo
Market Cap: Lowest
Employees: Low

Adzenys XR-ODT

Aytu Biopharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics and consumer healthcare products in the United States and internationally. They offer products for the treatment of ADHD, allergies, fluoride deficiency, cough, and insomnia.

Tags: ADHD, Allergies, Fluoride Deficiency, Healthcare, Insomnia, Pharmaceuticals, Therapeutics

Symbol: AYTU

Recent Price: $1.61

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Joshua R. Disbrow

Sector: Healthcare

Employees: 102

Address: 373 Inverness Parkway, Englewood, CO 80112

Phone: 720 437 6580

Last updated: 2024-12-31

Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

XTreo technology platform

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company developing integrated drug and delivery solutions for ear, nose, and throat diseases using its XTreo technology platform. It focuses on product candidates like LYR-210 and LYR-220 for chronic rhinosinusitis.

Tags: biotechnology, chronic rhinosinusitis, drug delivery, healthcare, therapeutics

Symbol: LYRA

Recent Price: $0.22

Industry: Biotechnology

CEO: Dr. Maria Palasis Ph.D.

Sector: Healthcare

Employees: 88

Address: 480 Arsenal Way, Watertown, MA 02472

Phone: 617 393 4600

Leadership

  • Harlan W. Waksal, M.D., Executive Chairman
  • Maria Palasis, Ph.D., President and Chief Executive Officer
  • Jason Cavalier, Chief Financial Officer
  • Robert Kern, M.D., Chief Clinical Advisor
  • Ronan O’Brien, Chief Legal Officer
  • Vineeta Belanger, Ph.D., Senior Vice President of Clinical Affairs
  • Gloria Cosgrove, Senior Vice President of Quality
  • Allison Nance, Senior Vice President of Regulatory Affairs
  • Michael Altman, CFA, Managing Director, Perceptive Advisors
  • Ann Merrifield, Life Sciences Advisor and Board Director
  • Konstantin Poukalov, Managing Director, Perceptive Advisors
  • Bradford Smith, Board Director
  • Nancy L. Snyderman, M.D., Board Director
  • Jim Tobin, Lead Independent Director
  • Robert Langer, D.Sc., David H. Koch Institute Professor, Massachusetts Institute of Technology
  • George Whitesides, Ph.D., Woodford L. and Ann A. Flowers University Professor, Harvard University

Last updated: 2024-12-31

Plus Therapeutics, Inc.

Plus Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Rhenium-186 Nano Liposome

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to developing, manufacturing, and commercializing treatments for cancer and other diseases. Its lead product, Rhenium-186 Nano Liposome, is a patented radiotherapy for central nervous system cancers.

Tags: cancer treatment, clinical-stage, glioblastoma, pharmaceuticals, radiotherapy

Symbol: PSTV

Recent Price: $1.15

Industry: Biotechnology

CEO: Dr. Marc H. Hedrick M.B.A., M.D.

Sector: Healthcare

Employees: 20

Address: 4200 Marathon Boulevard, Austin, TX 78756

Phone: 737 255 7194

Last updated: 2024-12-31

Tourmaline Bio, Inc.

Tourmaline Bio, Inc. logo
Market Cap: Medium
Employees: Low

medicines for immune diseases

Tourmaline Bio, Inc. is a clinical biotechnology company focused on developing medicines for patients with life-altering immune diseases, such as Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED).

Tags: ASCVD, TED, biotechnology, clinical development, immune diseases

Symbol: TRML

Recent Price: $20.08

Industry: Biotechnology

CEO: Dr. Sandeep C. Kulkarni M.D.

Sector: Healthcare

Employees: 70

Address: 27 West 24th Street, New York, NY 10010

Phone: 646-481-9832

Last updated: 2024-12-31

Aileron Therapeutics, Inc.

Aileron Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

ALRN-6924

Aileron Therapeutics, Inc. is a clinical stage oncology company developing ALRN-6924 for various cancer treatments, with multiple clinical trials in progress.

Tags: ALRN-6924, cancer therapies, chemoprotection, clinical stage, clinical trials, oncology

Symbol: ALRN

Recent Price: $2.32

Industry: Biotechnology

CEO: Dr. James Brian Windsor Ph.D.

Sector: Healthcare

Employees: 15

Address: 285 Summer Street, Boston, MA 02210

Phone: 617 995 0900

Last updated: 2024-12-31

Ardelyx, Inc.

Ardelyx, Inc. logo
Market Cap: High
Employees: Low

tenapanor

Ardelyx, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for gastrointestinal and cardiorenal therapeutic areas, including treatments for irritable bowel syndrome with constipation and hyperphosphatemia.

Tags: CKD, biopharmaceutical, cardiorenal, gastrointestinal, hyperkalemia, hyperphosphatemia, metabolic acidosis, tenapanor

Symbol: ARDX

Recent Price: $5.25

Industry: Biotechnology

CEO: Mr. Michael G. Raab

Sector: Healthcare

Employees: 267

Address: 400 Fifth Avenue, Waltham, MA 02451

Phone: 510 745 1700

Leadership

  • Justin Renz, Chief Financial & Operations Officer
  • Eric Foster, Chief Commercial Officer
  • Elizabeth Grammer, Esq., Chief Legal & Administrative Officer
  • Laura Williams, MD MPH, Chief Medical Officer
  • Robert Blanks, MS RAC, Chief Regulatory Affairs & Quality Assurance Officer
  • David Rosenbaum, PhD, Chief Development Officer
  • Mike Kelliher, Executive Vice President, Corporate Development and Strategy
  • Charon Spencer, Chief Human Resources Officer
  • David Mott, Chairman
  • Robert Bazemore, Director
  • William A. Bertrand, Jr., JD, Director
  • Muna Bhanji, R.Ph, Director
  • Onaiza Cadoret-Manier, Director
  • Mike Raab, Director
  • Richard Rodgers, Director

Last updated: 2024-12-31

BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

ORLADEYO

Bio Cryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering novel, oral, and small-molecule medicines, with marketed products including RAPIVAB and ORLADEYO, and a pipeline featuring BCX9930, BCX9250, and Galidesivir.

Tags: biotechnology, clinical trials, hereditary angioedema, influenza treatment, oral medicines, small-molecule medicines

Symbol: BCRX

Recent Price: $7.53

Industry: Biotechnology

CEO: Mr. Jon P. Stonehouse

Sector: Healthcare

Employees: 536

Address: 4505 Emperor Boulevard, Durham, NC 27703

Phone: 919 859 1302

Last updated: 2024-12-31

Heron Therapeutics, Inc.

Heron Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

SUSTOL, CINVANTI, ZYNRELEF

Heron Therapeutics, Inc. is a biotechnology company focused on developing treatments to address unmet patient needs, utilizing its proprietary Biochronomer drug delivery technology.

Tags: biotechnology, cancer treatment, chemotherapy, drug delivery, nausea prevention

Symbol: HRTX

Recent Price: $1.51

Industry: Biotechnology

CEO: Mr. Craig Alexander Collard

Sector: Healthcare

Employees: 126

Address: 4242 Campus Point Court, San Diego, CA 92121

Phone: 858 251 4400

Leadership

  • Adam Morgan, Chairman
  • Sharmila Dissanaike, M.D., FACS, FCCM, Director
  • Craig Johnson, Lead Independent Director
  • Susan Rodriguez, Director
  • Christian Waage, Director
  • Craig Collard, Director
  • Brett Fleshman, Chief Business Officer

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

Lipocine Inc.

Lipocine Inc. logo
Market Cap: Lowest
Employees: Lowest

TLANDO

Lipocine Inc. is a clinical-stage biopharmaceutical company focused on developing pharmaceutical products for neuroendocrine and metabolic disorders using oral delivery solutions. Its lead product is TLANDO, an oral testosterone replacement therapy.

Tags: biopharmaceutical, metabolic disorders, neuroendocrine disorders, oral delivery, testosterone therapy

Symbol: LPCN

Recent Price: $4.58

Industry: Biotechnology

CEO: Dr. Mahesh V. Patel Ph.D.

Sector: Healthcare

Employees: 17

Address: 675 Arapeen Drive, Salt Lake City, UT 84108

Phone: 801 994 7383

Last updated: 2024-12-31

Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc. logo
Market Cap: Medium
Employees: Lowest

lorundrostat

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for hypertension and associated cardiovascular diseases, with its lead product candidate being lorundrostat.

Tags: biopharmaceutical, cardiovascular diseases, hypertension, lorundrostat, therapies

Symbol: MLYS

Recent Price: $12.52

Industry: Biotechnology

CEO: Mr. Jon Congleton

Sector: Healthcare

Employees: 28

Address: 150 N. Radnor Chester Rd., Radnor, PA 19087

Phone: 888-378-6240

Last updated: 2024-12-31

Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

Roluperidone

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system diseases, including schizophrenia and Parkinson's disease.

Tags: Parkinson's disease, biopharmaceutical, central nervous system, neurodegenerative disorders, schizophrenia

Symbol: NERV

Recent Price: $2.29

Industry: Biotechnology

CEO: Dr. Remy Luthringer Ph.D.

Sector: Healthcare

Employees: 9

Address: 1601 Trapelo Road, Waltham, MA 02451

Phone: 617 600 7373

Leadership

  • Remy Luthringer, PhD, Executive Chairman of the Board, Chief Executive Officer
  • Geoff Race, FCMA, MBA, President
  • Michael Davidson, M.D., Chief Medical Officer
  • Frederick Ahlholm, CPA, Chief Financial Officer
  • Joseph Reilly, Senior Vice President and Chief Operating Officer
  • Jay Saoud, PhD, Consultant
  • Hans Peter Hasler, Board Member
  • Jan van Heek, Board Member
  • David Kupfer, MD, Board Member
  • Fouzia Laghrissi-Thode, MD, Board Member, Chief Executive Officer of DalCor Pharmaceuticals

Last updated: 2024-12-31

Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings, Inc. logo
Market Cap: Low
Employees: Low

Rani Pill

Rani Therapeutics Holdings, Inc. is a clinical stage biotherapeutics company focused on developing orally administered biologics with its Rani Pill platform, aimed at replacing subcutaneous or IV injections. The company has multiple products in various stages of development targeting conditions like neuroendocrine tumors, psoriatic arthritis, osteoporosis, growth hormone deficiency, hypoparathyroidism, and type 2 diabetes.

Tags: Rani Pill, biologics, biotherapeutics, clinical trials, healthcare, pharmaceuticals

Symbol: RANI

Recent Price: $1.48

Industry: Biotechnology

CEO: Mr. Talat Imran

Sector: Healthcare

Employees: 140

Address: 2051 Ringwood Avenue, San Jose, CA 95131

Phone: 408 457 3700

Leadership

  • Talat Imran, Chief Executive Officer
  • Mir Imran, Founder and Executive Chairman
  • Mir Hashim, Chief Scientific Officer
  • Svai Sanford, Chief Financial Officer
  • Eric Groen, General Counsel
  • Kate McKinley, Chief Business Officer
  • Jacques Van Dam, Vice President, Medical Affairs
  • Alireza Javadi, VP of Technical Operations
  • Betsy Gutierrez, Vice President, Quality Assurance
  • Bella Vazquez, Vice President, Human Resources
  • Kyle Horlen, VP of Nonclinical Development & Safety Assessment
  • Arvinder Dhalla, Vice President, Clinical Development
  • Andrew Farquharson, Managing Director, VHM and InCube Ventures
  • Maulik Nanavaty, CEO of Anumana
  • Jean-Luc Butel, Director at Takeda, Novo Holdings, and SG Innovate
  • Laureen DeBuono, Managing Partner, FLG Partners
  • Dennis Ausiello, Director of CATCH & Former Chief of Medicine, Mass General
  • Lisa Rometty, President, CVS Kidney Care

Last updated: 2024-12-31

Radius Health, Inc.

Radius Health, Inc. logo
Market Cap: Medium
Employees: High

TYMLOS

Radius Health, Inc. is a biopharmaceutical company focusing on unmet medical needs in bone health, orphan diseases, and oncology, with a commercial product TYMLOS for osteoporosis treatment.

Tags: biopharmaceutical, bone health, oncology, orphan diseases, osteoporosis

Symbol: RDUS

Recent Price: $15.00

Industry: Drug Manufacturers - Specialty & Generic

CEO: Ms. Tamara L. Lundgren J.D.

Sector: Healthcare

Employees: 3011

Address: 950 Winter St, Waltham, MASSACHUSETTS 02210

Phone: 16175514000

Last updated: 2024-12-31

Relay Therapeutics, Inc.

Relay Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

RLY-4008, RLY-2608, RLY-1971

Relay Therapeutics, Inc. is a clinical-stage company that focuses on precision medicine in oncology and genetic diseases by transforming the drug discovery process. Their leading products include small molecule inhibitors for advanced cancer treatment.

Tags: FGFR2, PI3Ka, Src homology, clinical-stage, drug discovery, genetic diseases, oncology, precision medicines, small molecule inhibitors

Symbol: RLAY

Recent Price: $4.18

Industry: Biotechnology

CEO: Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS

Sector: Healthcare

Employees: 323

Address: 399 Binney Street, Cambridge, MA 02139

Phone: 617 370 8837

Last updated: 2024-12-31

Unicycive Therapeutics, Inc.

Unicycive Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Renazorb, UNI 494

Unicycive Therapeutics is a biotech company developing novel therapies for kidney diseases in the United States, focusing on treatments for hyperphosphatemia and acute kidney injury.

Tags: Renazorb, UNI 494, acute kidney injury, biotechnology, hyperphosphatemia, kidney diseases

Symbol: UNCY

Recent Price: $0.58

Industry: Biotechnology

CEO: Dr. Shalabh K. Gupta M.D., MPA

Sector: Healthcare

Employees: 14

Address: 4300 El Camino Real, Los Altos, CA 94022

Phone: 650 351 4495

Last updated: 2024-11-08

Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock logo
Market Cap: Lowest
Employees: Lowest

Tecarfarin

Cadrenal Therapeutics, Inc. is a clinical development biopharmaceutical company focusing on novel therapies for preventing systemic thromboembolism in patients with specific health conditions, headquartered in Ponte Vedra, Florida.

Tags: Tecarfarin, atrial fibrillation, biopharmaceutical, cardiac, clinical development, end-stage renal disease, orphan drug, systemic thromboembolism

Symbol: CVKD

Recent Price: $14.23

Industry: Biotechnology

CEO: Mr. Quang X. Pham

Sector: Healthcare

Employees: 4

Address: 822 A1A North, Ponte Vedra, FL 32082

Phone: 904 300 0701

Last updated: 2024-12-31

Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Low

Paltusotine

Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on discovering, developing, and commercializing therapeutics for rare endocrine diseases and related tumors. Their leading product candidate, Paltusotine, has completed phase III trials for acromegaly treatment.

Tags: Paltusotine, biotechnology, clinical trials, endocrine diseases, pharmaceutical, therapeutics

Symbol: CRNX

Recent Price: $50.67

Industry: Biotechnology

CEO: Dr. R. Scott Struthers Ph.D.

Sector: Healthcare

Employees: 290

Address: Building No. 2, San Diego, CA 92121

Phone: 858 450 6464

Last updated: 2024-12-31

Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc. logo
Market Cap: Medium
Employees: Lowest

CTI-1601

Larimar Therapeutics, Inc. is a clinical-stage biotechnology company developing treatments for rare diseases using a novel cell penetrating peptide technology platform. Their lead product candidate, CTI-1601, is undergoing Phase 1 clinical trials to treat Friedreich's ataxia.

Tags: Friedreich's ataxia, biotechnology, cell penetrating peptide, clinical-stage, novel technologies, rare diseases

Symbol: LRMR

Recent Price: $3.91

Industry: Biotechnology

CEO: Dr. Carole S. Ben-Maimon M.D.

Sector: Healthcare

Employees: 42

Address: Three Bala Plaza East, Bala Cynwyd, PA 19004

Phone: 844 511 9056

Leadership

  • Carole Ben-Maimon, MD, President and Chief Executive Officer
  • Gopi Shankar, PhD, MBA, FAAPS, Chief Development Officer
  • Rusty Clayton, DO, Chief Medical Officer
  • Michael Celano, CHIEF FINANCIAL OFFICER
  • John Berman, Vice President of Finance and Administration
  • Jennifer Johansson, Vice President, Legal and Compliance
  • Keith E. Lynch, Jr., Vice President, CMC Technical Operations
  • Noreen Scherer, Vice President of Clinical Operations
  • Francis Michael Conway, CPA, VICE PRESIDENT AND CONTROLLER
  • Mohamed Hamdani, Vice President, Statistics and Quantitative Sciences
  • Adrienne Clements-Egan, Ph.D., Vice President, Bioanalytics and Developability
  • Frank Nazzario, RPh, Vice President, Commercial
  • Joseph Truitt, BOARD CHAIR
  • Tom Hamilton,
  • Jonathan Leff,
  • Frank E. Thomas,
  • Jeffrey Sherman, MD,
  • ,

Last updated: 2024-12-31

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

TERN-101, TERN-201, TERN-501, TERN-601

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.

Tags: NASH, biopharmaceutical, clinical trials, obesity, pharmaceutical research

Symbol: TERN

Recent Price: $7.15

Industry: Biotechnology

CEO: Ms. Amy L. Burroughs M.B.A.

Sector: Healthcare

Employees: 66

Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 525 5535

Last updated: 2024-11-08